INS and diabetes mellitus: Chronic low-grade inflammation, or “meta-inflammation,” is a hallmark of type 2 diabetes mellitus (T2DM), that disrupts glucose metabolism and insulin signaling in adipocytes, hepatocytes, and muscle cells.